Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Harari

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
European Journal of Immunology|August 18, 2005
Understanding what makes a good versus a bad vaccineAlexandre Harari, Giuseppe Pantaleo
The Journal of Experimental Medicine|June 11, 2024
Personalized cancer T-cell therapy takes the stage, mirroring vaccine successJohanna Chiffelle, Alexandre Harari
Nature Reviews. Immunology|April 20, 2006
Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseasesGiuseppe Pantaleo, Alexandre Harari
Advances in Pharmacology (San Diego, Calif.)|December 19, 2007
HIV-1-specific immune responseAlexandre Harari, Giuseppe Pantaleo
Cancer Cell|July 12, 2022
Immune pressure sculps tumor cells and trims high-quality mutationsMichal Bassani-Sternberg, Alexandre Harari
Journal for Immunotherapy of Cancer|September 18, 2015
Immune monitoring technology primer: flow and mass cytometryHolden T Maecker, Alexandre Harari
Cancers|November 27, 2021
Vaccines as Priming Tools for T Cell Therapy for Epithelial CancersLana E Kandalaft, Alexandre Harari
Current Opinion in HIV and AIDS|April 18, 2009
Phenotype and function of protective T cell immune responses in HIVMichael R Betts, Alexandre Harari
European Journal of Immunology|October 16, 2004
Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen loadAlexandre Harari, Florence Vallelian, Giuseppe Pantaleo
Current Opinion in HIV and AIDS|April 18, 2009
Role of HIV-1-specific CD4 T cellsAlexandre Harari, Cristina Cellerai, Giuseppe Pantaleo
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
European Journal of Immunology|August 18, 2005
Understanding what makes a good versus a bad vaccineAlexandre Harari, Giuseppe Pantaleo
The Journal of Experimental Medicine|June 11, 2024
Personalized cancer T-cell therapy takes the stage, mirroring vaccine successJohanna Chiffelle, Alexandre Harari
Nature Reviews. Immunology|April 20, 2006
Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseasesGiuseppe Pantaleo, Alexandre Harari
Advances in Pharmacology (San Diego, Calif.)|December 19, 2007
HIV-1-specific immune responseAlexandre Harari, Giuseppe Pantaleo
Cancer Cell|July 12, 2022
Immune pressure sculps tumor cells and trims high-quality mutationsMichal Bassani-Sternberg, Alexandre Harari
Journal for Immunotherapy of Cancer|September 18, 2015
Immune monitoring technology primer: flow and mass cytometryHolden T Maecker, Alexandre Harari
Cancers|November 27, 2021
Vaccines as Priming Tools for T Cell Therapy for Epithelial CancersLana E Kandalaft, Alexandre Harari
Current Opinion in HIV and AIDS|April 18, 2009
Phenotype and function of protective T cell immune responses in HIVMichael R Betts, Alexandre Harari
European Journal of Immunology|October 16, 2004
Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen loadAlexandre Harari, Florence Vallelian, Giuseppe Pantaleo
Current Opinion in HIV and AIDS|April 18, 2009
Role of HIV-1-specific CD4 T cellsAlexandre Harari, Cristina Cellerai, Giuseppe Pantaleo
Pageof 13